ROSEMARY
WANGENSTEEN FUENTES
TITULAR DE UNIVERSIDAD
French Institute of Health and Medical Research
París, FranciaFrench Institute of Health and Medical Research-ko ikertzaileekin lankidetzan egindako argitalpenak (1)
2008
-
Rosiglitazone, a peroxisome proliferator-activated receptor-γ agonist, prevents microparticle-induced vascular hyporeactivity through the regulation of proinflammatory proteins
Journal of Pharmacology and Experimental Therapeutics, Vol. 324, Núm. 2, pp. 539-547